Detalhe da pesquisa
1.
Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
J Drugs Dermatol
; 16(6): 591-598, 2017 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28686777
2.
Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
J Drugs Dermatol
; 15(8): 962-9, 2016 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27537997
3.
A causal model for joint evaluation of placebo and treatment-specific effects in clinical trials.
Biometrics
; 69(2): 318-27, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23432119
4.
Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
J Biopharm Stat
; 21(5): 938-53, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21830924
5.
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events.
Oncol Res Treat
; 44(10): 547-556, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34515215
6.
Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer.
Clin Cancer Res
; 27(2): 418-428, 2021 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32887722
7.
Real-World Evidence Utilization in Clinical Development Reflected by US Product Labeling: Statistical Review.
Ther Innov Regul Sci
; 54(6): 1436-1443, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32514737
8.
Benefit-Risk Evaluation and Decision Making: Some Practical Insights.
Ther Innov Regul Sci
; 49(3): 425-433, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30222397